HMS-020 - Association between chemotherapy-induced peripheral neuropathy and functional bowel disorders in cancer patients undergoing oxaliplatin-based chemotherapy: Evidence from real world data analysis

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HMS-020
• By: MIYAMOTO, Tomoyoshi (Division of Clinical Pharmacy, School of Pharmacy, Hyogo Medical University, Japan)
• Co-author(s): Dr Tomoyoshi Miyamoto (Division of Clinical Pharmacy, School of Pharmacy, Hyogo Medical University, Kobe, Japan / Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-osaka, Japan)
  Mr Takeshi Nakamura (Department of Pharmacy, Hyogo Medical University Hospital, Nishinomiya, Japan)
  Ms Maho Tsubota (Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-osaka, Japan)
  Ms Fumiko Sekiguchi (Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-osaka, Japan)
  Mr Takeshi Kimura (Department of Pharmacy, Hyogo Medical University Hospital, Nishinomiya, Japan)
  Ms Satoko Katsuragi (Division of Clinical Pharmacy, School of Pharmacy, Hyogo Medical University, Kobe, Japan)
  Mr Atsufumi Kawabata (Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-osaka, Japan)
  
• Abstract:

  [Background and Purpose] Cytotoxic anticancer agents cause a variety of adverse events that decrease the patients’ quality of life. Chemotherapy-induced peripheral neuropathy (CIPN) is one of the major concerns in cancer patients undergoing chemotherapy. In particular, oxaliplatin, a platinum-based anticancer drug, frequently causes severe..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login